Skip to main content

Things You Need to know About Xarelto

Xarelto is an anticoagulant (blood thinner) which blocks the activity of specific substances that are responsible for blood clotting. Although blood clotting is a natural process that helps in healing, the clots can also be form abnormally, break away into the blood stream and obstruct the flow of blood into body organs. 

Manufactured by Bayer and was released in the U.S. in 2011 by Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, Xarelto was designed to prevent or treat a type of blood clot called deep vein thrombosis (DVT) or pulmonary embolism (blood clots in the lungs, brain or heart). It is generally prescribed for patients undergoing certain types of surgeries, such as hip or knee replacement.

However, there have been complications reported by the patients after taking the drug. They claimed for xarelto legal compensation for all the pain and suffering.

Initially, Xarelto was marketed as a superior anticoagulant to other existing blood thinners, like warfarin. But what made it so popular is the most significant difference between the other drugs that it did not require regular blood monitoring, dietary restrictions, or frequent dose adjustments.

Xarelto Side Effects

But as mentioned, this popular drug was soon linked with various complications. Inherent to other anticoagulants, Xarelto also puts patients at risk of hemorrhaging and other internal bleeding chances. What made it dangerous is there's no way to stop severe bleeding events caused by Xarelto. Additionally, doctors find it more difficult to detect internal bleeding in patients taking this drug as there's no regular blood monitoring tests required with it.

The following health effects have been highlighted by the patients in xarelto legal compensation.
  • Intracranial hemorrhages
  • Abdominal bleeding
  • Retinal bleeding
  • Infection
  • Wound complications
  • Epidural hemorrhage
  • Adrenal bleeding
  • Excessive blood loss
  • Stroke
  • Death
FDA Issues Xarelto Warnings

The U.S. Food and Drug Administration (FDA) in June 2013 sent a letter to Bayer, Janssen, and Johnson & Johnson, warning that the drug's advertising was misleading and downplayed the possible fatal side effects. The FDA also claimed how the branding and advertisements for Xarelto failed to sufficiently draw attention to the potential effects of the drug and claims of its effectiveness appeared to be disengaged from its risks.

Moreover, the FDA cited inaccuracies in claims made by Xarelto’s manufacturers that it does not require dosage adjustments, but in actuality the product’s information sections have contradictory instructions on warnings and precautions as well as dosage and administration. The FDA issued a black box warning for Xarelto in August 2013 for its insufficient warning. The victims of the drug thus gained more courage to speak up for the xarelto legal compensation.

The warning from the agency highlighted that patients who discontinued Xarelto usage prematurely were at a higher risk for developing blood clots, DPV, and even might risk themselves for spinal or epidural hematoma. In 2014, the FDA required new language be included in the safety information and warning for the drug.

Absence of a Xarelto antidote to treat excessive bleeding has been the main health concern. The patients are left at the risk of forming blood clots if they prematurely stop taking the drug.
Patients filing for xarelto legal compensation claim:
  • It poses an unnecessary risk of injury through excessive bleeding
  • Lack of an antidote to stop excessive bleeding is an inherent design defect
Janssen and Bayer knew about the risks and intentionally concealed evidence

Comments

Popular posts from this blog

Severe And Mild Side Effects Of Xarelto

Xarelto is the brand name of Rivaroxaban which is manufactured by Bayer and the Johnson & Johnson subsidiary, Janssen. It is a popular blood thinner, an oral anticoagulant drug, which is prescribed for adults in the treatment of deep vein thrombosis (DVT), pulmonary embolisms (PE), atrial fibrillation (AFib), who undergoes hip and knee replacements. In 2011, the FDA approved the drug to be a safe and effective alternative for those who cannot tolerate anticoagulants. But soon after its release, there were hundreds of complications associated with the rug came into the picture. The life threatening side ffects lead to fatal consequences and the victims even filed for lawsuits. Following are some of the most common  xarelto side effects  which have been reported by the victims: Hemorrhage Pulmonary embolism (PE) Deep vein thrombosis (DVT) Unusual liver function Spinal epidural hematoma Leakage from the existing wound s The main idea of Xarelto is to prevent exce

Mild and Severe Xarelto Side Effects

Rivaroxaban is a type of drug known as an anticoagulant, or as commonly known as blood thinner. It belongs to a class of drugs called anticoagulants, specifically the factor Xa inhibitors (blockers). Xarelto, which is the brand name of the drug Rivaroxaban, is commonly used for a number of conditions such as: preventing stroke who suffer from nonvalvular atrial fibrillation preventing and treating blood clots in the blood vessels (blood clots are formed in certain veins of the legs and is called deep vein thromboses (DVT) . These clots can travel up to the lungs, resulting pulmonary embolisms) preventing PE and DVT after hip or knee replacement surgery reducing the risk of main cardiac problems such as heart attack or stroke in patients with peripheral artery disease (PAD) or  chronic coronary artery disease (CAD) However, there have been some serious studies about xarelto side effects . Rivaroxaban helps prevent blood clots by blocking a called factor Xa. Once bloc